241 related articles for article (PubMed ID: 24862968)
1. The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.
Zhang L; Hao JB; Ren LS; Ding JL; Hao LR
Lab Invest; 2014 Aug; 94(8):839-50. PubMed ID: 24862968
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model.
Nishimura H; Ito Y; Mizuno M; Tanaka A; Morita Y; Maruyama S; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2008 May; 294(5):F1084-93. PubMed ID: 18353870
[TBL] [Abstract][Full Text] [Related]
3. Prevention of lipopolysaccharide-induced peritoneal damage by eplerenone in rats undergoing peritoneal dialysis.
Tayama Y; Hasegawa H; Takayanagi K; Matsuda A; Shimizu T; Asakura J; Iwashita T; Ogawa T; Katoh H; Mitarai T
J Nephrol; 2013; 26(6):1160-9. PubMed ID: 24284522
[TBL] [Abstract][Full Text] [Related]
4. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Hong M; Nie Z; Chen Z; Yu X; Bao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
[TBL] [Abstract][Full Text] [Related]
5. Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis.
Li Z; Zhang L; He W; Zhu C; Yang J; Sheng M
Int J Mol Sci; 2014 Jul; 15(7):12959-71. PubMed ID: 25054320
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen Sulfide Alleviates Peritoneal Fibrosis via Attenuating Inflammation and TGF-β1 Synthesis.
Lu Y; Gao L; Li L; Zhu Y; Wang Z; Shen H; Song K
Nephron; 2015; 131(3):210-9. PubMed ID: 26529331
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients.
Donderski R; Stróżecki P; Sulikowska B; Grajewska M; Miśkowiec I; Stefańska A; Siódmiak J; Odrowąż-Sypniewska G; Manitius J
Int Urol Nephrol; 2017 Oct; 49(10):1867-1873. PubMed ID: 28710615
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model.
Chunming J; Miao Z; Cheng S; Nana T; Wei Z; Dongwei C; Yuan F
Ren Fail; 2011; 33(3):355-62. PubMed ID: 21401363
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
Ueno T; Nakashima A; Doi S; Kawamoto T; Honda K; Yokoyama Y; Doi T; Higashi Y; Yorioka N; Kato Y; Kohno N; Masaki T
Kidney Int; 2013 Aug; 84(2):297-307. PubMed ID: 23486522
[TBL] [Abstract][Full Text] [Related]
12. Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis.
Zhang Y; Feng W; Peng X; Zhu L; Wang Z; Shen H; Chen C; Xiao L; Li S; Zhao Y; Lin M; Huang Y; Long H; Liang J
Lab Invest; 2022 Dec; 102(12):1346-1354. PubMed ID: 36307537
[TBL] [Abstract][Full Text] [Related]
13. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
[TBL] [Abstract][Full Text] [Related]
14. Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis.
Asai M; Monkawa T; Marumo T; Fukuda S; Tsuji M; Yoshino J; Kawachi H; Shimizu F; Hayashi M; Saruta T
Hypertens Res; 2004 Dec; 27(12):971-8. PubMed ID: 15894838
[TBL] [Abstract][Full Text] [Related]
15. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Yang LY; Chen A; Huang TP
Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats.
Li L; Shen N; Wang N; Wang W; Tang Q; Du X; Carrero JJ; Wang K; Deng Y; Li Z; Lin H; Wu T
Kidney Int; 2018 Jun; 93(6):1384-1396. PubMed ID: 29571940
[TBL] [Abstract][Full Text] [Related]
17. Suramin inhibits the development and progression of peritoneal fibrosis.
Xiong C; Liu N; Fang L; Zhuang S; Yan H
J Pharmacol Exp Ther; 2014 Nov; 351(2):373-82. PubMed ID: 25168661
[TBL] [Abstract][Full Text] [Related]
18. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
[TBL] [Abstract][Full Text] [Related]
20. The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats.
Ersoy R; Celik A; Yilmaz O; Sarioglu S; Sis B; Akan P; Yenicerioglu Y; Ormen M; Camsari T
Perit Dial Int; 2007; 27(4):424-31. PubMed ID: 17602151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
